Developmental outcome after exposure to cyclooxygenase inhibitors during pregnancy and lactation

Reproductive Toxicology

Volumn 32, Issue 4, 2011, Pages 407-417

  Burdan, Franciszek ^a,b   Pliszczynska Steuden, Malgorzata ^a   Rozylo Kalinowska, Ingrid ^a   Chalas, Anna ^a,c   Rozylo, T Katarzyna ^a   Staroslawska, Elzbieta ^b   Klepacz, Robert ^a   Szumilo, Justyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b ST JOHN S CANCER CENTER   (Poland)

^c Jan Bozy District Hospital   (Poland)

Author keywords

Bone; COX 1; COX 2; Cyclooxygenase; Cyclooxygenase inhibitors; Developmental toxicity; Drug effect; NSAID

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; IBUPROFEN; PIROXICAM; TOLMETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELIVERY; DEVELOPMENTAL TOXICITY; DIGITAL RADIOGRAPHY; DRUG EXPOSURE; FEMALE; FETUS; FETUS WEIGHT; LACTATION; MALE; MORPHOLOGY; NONHUMAN; OPTICAL DENSITY; PREGNANCY; RAT; STAINING; TOXICITY;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CALCIFICATION, PHYSIOLOGIC; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; LACTATION; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; RATS; RATS, WISTAR;

RATTUS;

EID: 80055035852     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.09.012     Document Type: Article

References (51)

1. Briggs G.G., Freeman R., Yaffe S.J. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk 1998, Williams and Wilkins, Baltimore. 5th ed.
2. Cappon G.D., Gupta U., Cook J.C. Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development. Birth Defects Res B Dev Reprod Toxicol 2003, 68:47-56.
3. Cook J.C., Jacobson C.F., Gao F., Tassinari M.S., Hurtt M.E., DeSesso J.M. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Res B Dev Reprod Toxicol 2003, 68:5-26.
4. Burdan F., Szumilo J., Dudka J., Korobowicz A., Klepacz R. Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors. Braz J Med Biol Res 2006, 39:925-934.
5. Burdan F., Szumilo J., Dudka J., Korobowicz A., Klepacz R. Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. Pharmacol Res 2006, 53:287-292.
6. Werler M.M., Sheehan J.E., Mitchell A.A. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 2002, 155:26-31.
7. Ostensen M., Skomsvoll J.F. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004, 5:571-580.
8. Ofori B., Oraichi D., Blais L., Rey E., Berard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006, 77:268-279.
9. Ostensen M., Khamashta M., Lockshin M., Parke A., Brucato A., Carp H., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006, 8:209-334.
10. Takahashi Y., Roman C., Chemtob S., Tse M.M., Lin E., Heymann M.A., et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol: Regul Integr Comp Physiol 2000, 278:R1496-R1505.
11. Temprano K.K., Bandlamudi R., Moore T.L. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005, 35:112-121.
12. US Food and Drug Administration Good laboratory practice for nonclinical laboratory studies March 21, 1994, Code of Federal Regulations (CFR), 56FR12300.
13. Claudio L., Bearer C.F., Hallinga D. Assessment of the US Environmental Protection Agency methods for identification hazards to developing organisms. Part II: the developmental toxicity testing guideline. Am J Inter Med 1999, 35:554-563.
14. EMEA. Note for guidance on repeated dose toxicity CMP/SWP/1042/99. http://www.emea.eu.int/.
15. World Health Organization Principles for evaluating health risk to reproduction associated with exposure to chemicals. Environ Health Criteria 2001, 225:1-185.
16. PDR Physicians' desk reference 1998, Medical Economics Company, Montvale, p. 153-1545, 2056-2058, 2179-2181. 52nd ed.
17. Pescar B.M., Ehrlich K., Pescar B.A. Interaction of COX-2 inhibitors and salicylate in gastric mucosal damage. Eur J Pharmacol 2002, 434:65-70.
18. Burdan F., Szumilo J., Dudka J., Klepacz R., Błaszczak M., Solecki M., et al. Morphological studies in modern teratological investigations. Folia Morphol (Warsz) 2005, 64:1-8.
19. Burdan F., Rozylo-Kalinowska I., Rozylo T.K., Chahoud I. A new rapid radiological procedure for routine teratological use in bone ossification assessment: a supplement for staining methods. Teratology 2002, 66:315-325.
20. Różyło-Kalinowska I., Michalska A., Burdan F. Optimization of analysis of skeletal ossification of laboratory animals by means of digital radiography software options. Ann Univ Mariae Curie Sklodowska Med 2003, 58:94-100.
21. Young A.D., Phipps D.E., Astroff A.B. Large-scale double-staining of rat fetal skeletons using alizarin red S and alcian blue. Teratology 2000, 61:273-276.
22. Solecki R., Bergmann B., Burgin H., Buschmann J., Clark R., Druga A., et al. Harmonization of rat fetal external and visceral terminology and classification. Reprod Toxicol 2003, 17:625-637.
23. Solecki R., Burgin H., Buschmann J., Clark R., Duverger M., Fialkowski O., et al. Harmonisation of rat fetal skeletal terminology and classification - report of the third workshop on the terminology in developmental toxicology. Reprod Toxicol 2001, 15:713-721.
24. Christian M.S. Test methods for assessing female reproductive and developmental toxicology. Principles and methods of toxicology 2001, 1301-1381. Taylor & Francis, Philadelphia. 4th ed. A.W. Hayes (Ed.).
25. Paumgartten F., Solecki R., Buschmann J., Clark R., Grote K., Rauch M., et al. Harmonization of terminology in developmental toxicology: the quest for a more precise description and a harmonized classification of fetal observations. Reprod Toxicol 2009, 27:8-13.
26. DevTox. http://www.devtox.org/.
27. Burdan F., Rozylo-Kalinowska I., Szumiło J., Dudka J., Klepacz R. Cyclooxygenase inhibitors affect bone mineralisation in rat fetuses. Cells Tissues Organs 2008, 187:221-232.
28. Burdan F., Szumilo J., Klepacz R., Dudka J., Korobowicz A., Tokarska E., et al. Gastrointestinal and hepatic toxicity of selective and nonselective cyclooxygenase-2 inhibitors in pregnant and nonpregnant rats. Pharmacol Res 2004, 50:534-544.
29. Burdan F., Szumilo J., Klepacz R. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development. Reprod Toxicol 2009, 28:239-244.
30. Chalas A. [Organ toxicity of selective and non-selective cyclooxygenase-2 inhibitors administered during pregnancy and lactation to Wistar rats] - PhD dissertation medical. Lublin: University of Lublin; 2006 (in Polish).
31. Burdan F. Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats. Birth Defects Res B Dev Reprod Toxicol 2004, 71:321-330.
32. Burdan F. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats - DFU and piroxicam study. Toxicology 2005, 211:12-25.
33. Manson J.M., Kang Y.J. The methods for assessing female reproductive and developmental toxicology. Principles and method of toxicology 1994, 989-1037. Raven Press, New York. 3rd ed. A. Hayes (Ed.).
34. Adams S.S., Bough R.G., Cliffe E.E., Lessel B., Mills R.F. Absorption distribution and toxicity of ibuprofen. Toxicol Appl Pharmacol 1969, 15:310-330.
35. Nishimura K., Fukagawa S., Shigematsu K. Teratogenicity study of 1-methyl-5-ptoluylopyrrole-2-acetate sodium dihydrate (tolmetin sodium) in rabbits. Iykuhin Kenkyu 1977, 8:158-164.
36. Perraud J. Reproductive studies with the anti-inflammatory agent piroxicam: modification classical protocols. Toxicology 1984, 30:59-63.
37. Cappon G.D., Fleeman T.L., Cook J.C., Hurtt M.E. Combined treatment potentiates the developmental toxicity of ibuprofen and acetazolamide in rats. Drug Chem Toxicol 2005, 28:409-421.
38. Burdan F., Dudka J., Szumiło J., Korobowicz A., Klepacz L. Prenatal effects of DuP-697 - the irreversible highly selective cyclooxygenase-2 inhibitor. Reprod Toxicol 2003, 17:413-919.
39. PDR Physicians' desk reference - electronic library release 2003, AX Thompson, CD-ROM.
40. Khera K.S. Common fetal aberration and their teratogenic significance: a review. Fundam Appl Toxicol 1981, 1:13-18.
41. Beck S.L. Prenatal and postnatal assessment of maneb-exposed CD-1 mice. Reprod Toxicol 1990, 4:283-290.
42. Chernoff N., Rogers J.M., Turner C.I., Francis B.M. Significance of supernumerary ribs in rodent developmental toxicity studies: postnatal persistence in rats and mice. Fundam Appl Toxicol 1991, 17:448-453.
43. Tothill P., Hannan W.J. Bone mineral and soft tissue measurements by dual-energy X-ray absorptiometry during growth. Bone 2002, 31:492-496.
44. Zuhlke U., Mohr S. Future trends in primate toxicology and refined techniques. Towards new horizons in primate toxicology 2000, 233-242. Münster, Wamann. R. Korte, G.F. Weinbauer (Eds.).
45. Lee T.C., Mohsin S., Taylor D., Perkesh R., Gunnlaugsson T., O'Brien F.J.O., et al. Detecting microdamage in bone. J Anat 2003, 203:161-172.
46. Chahoud I., Paumgartten F.J. Relationship between fetal body weight of Wistar rats at term and the extent of skeletal ossification. Braz J Med Biol Res 2005, 38:565-575.
47. Reid I.R. Relationship among body mass its components and bone. Bone 2002, 31:547-555.
48. Solecki M. [Tumor necrosis factor gene expression and morphology of epiphyseal cartilage in rats offspring exposed to cyclooxygenase inhibitors] - PhD dissertation. Lublin: Medical University of Lublin; 2007 (in Polish).
49. Zuchnik-Wrona A. [Morphology of the shoulder and elbow joint, and expression of COX-1 and COX-2 genes in the epiphyseal cartilage in rats offsprings exposed to cyclooxygenase inhibitors during pregnancy and lactation] - PhD dissertation. Lublin: Medical University of Lublin; 2011 (in Polish).
50. Clark R.L., Robertson R.T., Minsker D.H., Cohen S.M., Tocco D.J., Allen H.L., et al. Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits. Teratology 1984, 30:319-332.
51. Oster M.E., Riehle-Colarusso T., Alverson C.J., Correa A. Associations between maternal fever and influenza and congenital heart defects. J Pediatr 2011, 158:905-990.